Data as of Nov 4, 2026.
FMED vs GXDW: Holdings Overlap & Returns
Over the year to Nov 4, 2026, FMED returned +27.4% to GXDW's −13.8%; 0% of their weight is in the same names.
askIQ about this page
askIQ about FMED and GXDWNet assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $6.0m on Oct 12, 2026 for Global X Dorsey Wright Thematic ETF.
22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.
0% of GXDW's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026.
Pair scorecard
Both cost 0.50% a year; their one-year returns differ by 41.2 points.
| Measure | FMED | GXDW |
|---|---|---|
| Return | ||
| Total return, 1 year | +27.4% | −13.8% |
| Drawdown | ||
| Below its all-time high | 61.7%, high on Feb 10, 2021 | |
| Benchmark | ||
| What it tracks | Broad innovation and megatrends | Broad innovation and megatrends |
| Cost and size | ||
| Expense ratio | 0.50% | 0.50% |
| Net assets, FMED as of Sep 30, 2026 and GXDW as of Oct 12, 2026 | $52m | $6.0m |
| Holdings | ||
| Holdings in common | 0% | |
What they share
By the books each fund has filed, FMED and GXDW hold 0% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026.
half
0% in common
Only in one fund ↓
Window by window
| Total return | ||
|---|---|---|
| Window | FMED | GXDW |
| 3 months | +14.9% | −4.0% |
| 6 months | +31.2% | −20.3% |
| 1 year | +27.4% | −13.8% |
| 3 years | +57.8% | +7.4% |
| Since launchNot the same days: FMED Jun 2023 · GXDW Nov 2019 | +31.7% | −3.6% |
Side by side
As of Nov 4, 2026. Source: ETFIQ.
0% of the two portfolios are the same securities at the same weight.
FMED
By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.
GXDW
By weight, 0% of GXDW's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 100% of the fund across 5 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned −13.8% with distributions reinvested. It sits 61.7% below its all-time high of Feb 10, 2021.
Questions people ask
- Do FMED and GXDW hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, FMED against GXDW, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-gxdw
ETFIQ. (Nov 4, 2026). FMED against GXDW. Retrieved from https://etfiq.com/compare/themes/fmed-vs-gxdw
[FMED against GXDW (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/fmed-vs-gxdw)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.